Facilitating treatment of HCV in primary care in regional Australia: closing the access gap

BACKGROUND: Australia has unrestricted access to direct-acting antivirals (DAA) for hepatitis C virus (HCV) treatment. In order to increase access to treatment, primary care providers are able to prescribe DAA after fibrosis assessment and specialist consultation. Transient elastography (TE) is reco...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Frontline Gastroenterol
Autors principals: White, Lauren, Azzam, Ali, Burrage, Lauren, Orme, Clare, Kay, Barbara, Higgins, Sarah, Kaye, Simone, Sloss, Andrew, Broom, Jennifer, Weston, Nicola, Mitchell, Jonathan, O’Beirne, James
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2019
Matèries:
Liver
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583569/
https://ncbi.nlm.nih.gov/pubmed/31288252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/flgastro-2018-101049
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars